DHFR and neoplasm: Methotrexate, a chemotherapeutic drug, plays a key role in the treatment of various cancers (26), mainly by inhibiting dihydrofolate reductase to block the synthesis of tumor cells, thus inhibiting the growth and proliferation of tumors.